Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Algert Global LLC

Algert Global LLC grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 29.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 248,142 shares of the company's stock after purchasing an additional 56,235 shares during the period. Algert Global LLC owned about 0.15% of Option Care Health worth $5,757,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the fourth quarter valued at $26,000. UMB Bank n.a. lifted its stake in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC grew its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its position in shares of Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Option Care Health in the 4th quarter valued at $47,000. Institutional investors and hedge funds own 98.05% of the company's stock.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on OPCH shares. Barrington Research reiterated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and upped their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Stock Performance

NASDAQ OPCH traded up $0.14 on Friday, hitting $31.84. 1,566,842 shares of the company's stock were exchanged, compared to its average volume of 1,843,451. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm's 50-day moving average price is $33.24 and its two-hundred day moving average price is $28.89. The firm has a market cap of $5.21 billion, a price-to-earnings ratio of 26.76, a P/E/G ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. Option Care Health's revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.26 earnings per share. On average, research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.